Oric Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:ORIC) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 302.07 M274.14 M242.86 M346.86 M431.19 M408.89 M Total liabilities 28.08 M31.02 M23.12 M22.86 M24.27 M24.53 M Total equity 273.99 M243.12 M219.74 M324 M406.92 M384.36 M Total liabilities & shareholders' equities 302.07 M274.14 M242.86 M346.86 M431.19 M408.89 M Total debt —————— Net debt ——————

Nachrichten

H.C. Wainwright hebt Kursziel für ORIC Pharmaceuticals nach Studienfortschritten an

H.C. Wainwright raises ORIC Pharmaceuticals price target on trial progress

Oppenheimer bestätigt Outperform-Rating für ORIC-Aktie mit Kursziel von $15

Oppenheimer reiterates Outperform on ORIC stock, $15 target

Oric Pharmaceuticals: Neues ATM-Programm über 200 Millionen US-Dollar aufgelegt

Oric Pharmaceuticals files new $200 million at-the-market offering prospectus

Oric Pharmaceuticals: Direktor Heyman verkauft Aktien im Wert von 80.430 $

Oric Pharmaceuticals director Heyman sells shares worth $80,430

ORIC: Transition To Late-Stage Development Presents Upside (NASDAQ:ORIC)

Oric Pharmaceuticals Stock Sees Healthy RS Rating Jump To 80

H.C. Wainwright bestätigt Kaufempfehlung für ORIC Pharmaceuticals vor ereignisreichem Jahr 2026

H.C. Wainwright reiterates Buy rating on ORIC Pharmaceuticals stock